Research on the improvement effect of spasticity by extracorporeal shock wave

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCTs052190050

Enrollment

100

Registered

2019-09-11

Start date

2019-09-11

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Central neuropathy (cerebral palsy, cerebral hemorrhage, cerebral infarction, acute encephalopathy s cerebral palsy, stroke

Interventions

Irradiate upper and lower leg spastic muscles three times with extracorporeal shock wave

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Central nervous disorder with spasticity in upper and lower extremity muscles 2. Orthopedic surgery, botulinum therapy, baclofen intrathecal treatment not received within the past 6 months 3. Written informed consent has been obtained from the person or the principal regarding participation in this examination

Exclusion criteria

Exclusion criteria: 1. Oral administration of anticoagulant 2. Patients with thrombosis, patients with malignancy Patients who have been receiving cortisone treatment for 3.6 months or more or who have not been 6 weeks since the last cortisone injection 4. May be pregnant or pregnant

Design outcomes

Primary

Measure	Time frame
1. Measurement of adjacent joint range of motion of irradiated muscle 2. Spasticity assessment with Modified Ashworth Scale (MAS)	—

Secondary

Measure	Time frame
Spasticity assessment with Modified Tardieu Scale(MTS)	—

Contacts

Public ContactKiyoshi Yoshida

Osaka Children's Rehbilitation Hosipital

yoshida-kiyoshi@umin.ac.jp+81-6-6699-8731

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026